Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-018316

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jason Gardner
Officer — See Remarks · Director
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 25, 2018C25,719—A292,990IBy J.P. Gardner Irrevocable Trust
Common StockF1Jun 25, 2018C21,677—A359,092IBy P.S. Gardner Irrevocable Trust
Common StockF2Jun 25, 2018P400$15.00A363,212D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF1—Jun 25, 2018C30,000D——Common Stock11,6110I
Series A Preferred StockF1—Jun 25, 2018C36,700D——Common Stock14,2030I
Series B Preferred StockF1—Jun 25, 2018C15,000D——Common Stock5,8040I
Series B Preferred StockF1—Jun 25, 2018C19,314D——Common Stock7,4740I
Series C Preferred StockF1—Jun 25, 2018C21,459D——Common Stock8,3040I

Explanation of responses

Remarks

President & Chief Executive Officer